Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study-Reference-Cited by-同舟云学术

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

Published:2016-09 Issue:6 Volume:80 Page:424-431
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Singh Jaskaran B.,Fedgchin Maggie,Daly Ella,Xi Liwen,Melman Caroline,De Bruecker Geert^ORCID,Tadic Andre,Sienaert Pascal,Wiegand Frank,Manji Husseini,Drevets Wayne C.,Van Nueten Luc

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference34 articles.

1. The Global Burden of Disease: 2004 Update,2008

2. Grand challenges in global mental health;Collins;Nature,2011

3. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression;Gaynes;Psychiatr Serv,2009

4. Definition and epidemiology of treatment-resistant depression;Fava;Psychiatr Clin North Am,1996

5. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report;Rush;Am J Psychiatry,2006

Cited by 340 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shared effects of electroconvulsive shocks and ketamine on neuroplasticity: A systematic review of animal models of depression;Neuroscience & Biobehavioral Reviews;2024-09

2. Efficacy of ketamine versus esketamine in the treatment of perioperative depression: A review;Pharmacology Biochemistry and Behavior;2024-09

3. Ketamine and its two enantiomers in anesthesiology and psychiatry: A historical review and future directions;Journal of Anesthesia and Translational Medicine;2024-09

4. A Multi-Center, Open-Label, Single-Arm Study to Investigate the Early Effectiveness of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Using a Mobile Self-Monitoring Application;Pharmaceuticals;2024-08-30

5. The quest for optimal ketamine dosing formula in treatment-resistant major depressive disorder;Pharmacological Reports;2024-08-26